Factor | Early Diagnosis (DI ≤ 3months) n (%) | Late Diagnosis (DI > 3months) n (%) | Unadjusted Prevalence Ratio (95%CI) | Adjusted Prevalence Ratio (95%CI) |
---|---|---|---|---|
Age/years | Â | Â | Â | Â |
< 40 | 44 (55.7) | 35 (44.3) | 1.00 | 1.00 |
40-<50 | 65 (50.0) | 65 (50.0) | 0.89 (0.69–1.17) | 0.92 (0.70–1.21) |
50-<60 | 47 (43.5) | 61 (56.5) | 0.78 (0.58–1.05) | 0.75 (0.55–1.02) |
≥ 60 | 44 (51.2) | 42 (48.8) | 0.92 (0.69–1.22) | 1.06 (0.76–1.47) |
Marital Status | Â | Â | Â | Â |
Single | 11 (55.0) | 9 (45.0) | 1.00 | 1.00 |
Divorced | 28 (47.5) | 31 (52.5) | 0.86 (0.53–1.39) | 0.85 (0.52–1.36) |
Married | 100 (50.0) | 100 (50.0) | 0.91 (0.60–1.38) | 0.94 (0.60–1.47) |
Widowed | 61 (49.2) | 63 (50.8) | 0.89 ( 0.58–1.38) | 0.83 (0.53–1.30) |
Residence | Â | Â | Â | Â |
Rural | 105 (46.7) | 120 (53.3) | 1.00 | 1.00 |
Urban | 95 (53.4) | 83 (46.6) | 1.14 (0.94–1.39) | 1.14 (0.92–1.40) |
Education | Â | Â | Â | Â |
None | 40 (46.5) | 46 (53.5) | 1.00 | 1.00 |
Primary | 72 (48.3) | 77 (51.7) | 1.04 (0.78–1.40) | 1.04 (0.79–1.37) |
Secondary | 65 (52.0) | 60 (48.0) | 1.12 (0.84–1.48) | 1.07 (0.78–1.47) |
Tertiary | 23(53.5) | 20(46.5) | 1.15 (0.80–1.65) | 1.08 (0.72–1.61) |
Formal employment Status | Â | Â | Â | Â |
Unemployed | 132 (46.0) | 155 (54.0) | 1.00 | 1.00 |
Employed | 68 (58.6) | 48 (41.4) | 1.28 (1.05–1.55) | 1.22 (0.96–1.55) |
Prior Information on Cervical cancer | Â | Â | Â | Â |
No | 28 (43.8) | 36 (56.2) | 1.00 | 1.00 |
Yes | 172 (50.7) | 167 (49.3) | 1.16 (0.86–1.56) | 1.07 (0.80–1.43) |
Family History of Cervical cancer | Â | Â | Â | Â |
No/Don’t know | 185 (49.7) | 187 (50.3) | 1.00 | 1.00 |
Yes | 15 (48.4) | 16 (51.6) | 0.97 (0.67–1.42) | 0.98 (0.69–1.39) |
Ever done PAP Smear | Â | Â | Â | Â |
No | 42 (58.3) | 30 (41.7) | 1.00 | 1.00 |
Yes | 141 (47.3) | 157 (52.7) | 1.33 (0.83–2.15) | 1.39 (0.91–2.12) |
Person first Discussed symptoms with | Â | Â | Â | Â |
Health workers | 42 (58.3) | 30 (41.7) | 1.00 | 1.00 |
Relative | 141 (47.3) | 157 (52.7) | 0.81 (0.65–1.02) | 0.77 (0.60–0.98)* |
Spiritual or Traditional healer | 17 (51.5) | 16 (48.5) | 0.88 (0.60–1.29) | 1.00 (0.68–1.49) |
Level of Referring health facility (HF) | Â | Â | Â | Â |
Self-referral | 24 (34.3) | 46 (65.7) | 1.00 | 1.00 |
Private Clinics | 10 (40.0) | 15 (60.0) | 1.17 (0.65–2.08)) | 1.35 (0.78–2.34) |
Level4 (HCIVs) | 13 (61.9) | 8 (38.1) | 1.81 (1.13–2.88) | 1.54 (0.97–2.45) |
Level5 (DHs) | 40 (76.9) | 12 (23.1) | 2.24 (1.56–3.21) | 2.29 (1.60–3.26)* |
Level6 (RRHs) | 67 (46.8) | 76 (53.2) | 1.37 (0.95–1.98) | 1.40 (0.99-2.00) |
Level7 (NRHs) | 46 (50.0) | 46 (50.0) | 1.46 (0.99–2.14) | 1.36 (0.93–1.97) |
Distance to Nearest HF | Â | Â | Â | Â |
< 5 km | 138 (54.5) | 115 (45.5) | 1.00 | 1.00 |
≥ 5 km | 62 (41.3) | 88 (58.7) | 0.76 (0.61–0.95) | 0.84 (0.68–1.04) |
No of Pre-referral Visits | Â | Â | Â | Â |
≤ 2 times | 53 (60.9) | 34 (39.1) | 1.00 | 1.00 |
> 2times | 147 (46.5) | 169 (53.5) | 0.76 (0.62–0.94) | 0.75 (0.61–0.92)* |
Composite stage | Â | Â | Â | Â |
I/II | 134 (55.4) | 108 (44.6) | 1.00 | 1.00 |
III/IV | 66 (41.0) | 95 (59.0) | 0.74 (0.59–0.92) | 0.68 (0.55–0.85)* |
Histology type | Â | Â | Â | Â |
Adenocarcinoma and others | 19 (34.5) | 36 (65.5) | 1.00 | 1.00 |
Squamous cell carcinoma | 181 (52.0) | 167 (48.0) | 1.51 (1.03–2.20) | 1.55 (1.07–2.23)* |